Cargando…
Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology
Serotonin reuptake inhibitors and benzodiazepines are evidence-based pharmacological treatments for Anxiety Disorders targeting serotonin and GABAergic systems, respectively. Although clearly effective, these medications fail to improve anxiety symptoms in a significant proportion of patients. New i...
Autores principales: | Nasir, Madeeha, Trujillo, Daniel, Levine, Jessica, Dwyer, Jennifer B., Rupp, Zachary W., Bloch, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710541/ https://www.ncbi.nlm.nih.gov/pubmed/33329087 http://dx.doi.org/10.3389/fpsyt.2020.548505 |
Ejemplares similares
-
Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
por: Sarawagi, Ajay, et al.
Publicado: (2021) -
Editorial: Magnetic Resonance Spectroscopy of GABA and Glutamate in Mental Health
por: Otaduy, Maria Concepcion Garcia
Publicado: (2022) -
Knowledge atlas of the involvement of glutamate and GABA in alcohol use disorder: A bibliometric and scientometric analysis
por: Wang, Zhanzhang, et al.
Publicado: (2022) -
Increased Absolute Glutamate Concentrations and Glutamate-to-Creatine Ratios in Patients With Methamphetamine Use Disorders
por: Yang, Wenhan, et al.
Publicado: (2018) -
Intelligence and Brain Efficiency: Investigating the Association between Working Memory Performance, Glutamate, and GABA
por: Marsman, Anouk, et al.
Publicado: (2017)